Scenario:
- 1-2023 Bx Liver+ Adenocarcinoma
- Oncologist/GI Multidisciplinary Conference Stage IV (cT2N1M1) intrahepatic cholangiocarcinoma with pulmonary metastases, regional lymphadenopathy, and multifocal hepatic involvement
Question: How should histology be assigned?
- 8140 Adenocarcinoma
- 8160 Cholangiocarcinoma
Rationale:
2024 Solid Tumor Rules Other-NOTE Table 9a can be applied to cases diagnosed 2023 forward.
